ABRT:CC News and Press, Albert Labs International Corp. From 06/01/22

There exists no shortage of treatment options for cancer, from radiotherapy and chemotherapy to experimental options like immunotherapy. Yet, in spite of all the research and experimentation around the disease itself, there are relatively few options for treating cancer's psychological ...

​Overview Cancer treatments have come a long way, but they have a major blind spot that needs to be addressed: mental health associated with the diagnosis. In 2020, there were 18 million new cancer cases globally, and that’s expected to climb to 27.5 millio...

Albert Labs Appoints Principal Investigator for Real World Evidence Study for KRN-101 Canada NewsWire Albert Labs Appoints Dr Sara Tai as Principal Investigator for upcoming RWE Study on KRN-101 VANCOUVER, BC , May 26, 2022 /CNW/ - Alb...

Albert Labs Granted Health Canada Licence Canada NewsWire Albert Labs has been issued a Health Canada License enabling the possession, production, and delivery of psilocybin and other psychoactive controlled substances VANCOUVER, BC , May 16, 2022 ...

Albert Labs' Pre-Clinical Analytical and Toxicological Research Supports Company's Forthcoming Studies Canada NewsWire World-renowned scientists from the University of CESPU Health Sciences Department, Portugal are working in partnership with Albert Labs' exp...

Albert Labs Announces the Addition of Two Renowned Scientific Advisors to its Scientific Advisory Board (SAB) Canada NewsWire Professor Robert Britton and Dr Ricardo Jorge Dinis-Oliveira bring drug development and pharmacology/toxicological expertise to Alb...

Albert Labs Files US Provisional Patent Application and Proves Out Consistent and Rapidly Scalable Production of Psilocybe and Other Mycelia Canada NewsWire Albert Labs' Files U.S. Provisional Patent Application for a Cultivation Process for the Production of Psi...